Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease

Background/Aims Exclusive enteral nutrition (EEN), an established modality for pediatric Crohn’s disease (CD) is seldomly utilized in adults. The present study reports the outcome of EEN in adult CD patients at a tertiary care hospital in India. Methods This was a retrospective analysis of CD patien...

Full description

Bibliographic Details
Main Authors: Sanchit Sharma, Arti Gupta, Saurabh Kedia, Samagra Agarwal, Namrata Singh, Sandeep Goyal, Saransh Jain, Vipin Gupta, Pabitra Sahu, Sudheer Kumar Vuyyuru, Bhaskar Kante, Raju Sharma, Rajesh Panwar, Peush Sahni, Govind Makharia, Vineet Ahuja
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2021-07-01
Series:Intestinal Research
Subjects:
Online Access:http://irjournal.org/upload/pdf/ir-2019-09172.pdf
_version_ 1818456135309459456
author Sanchit Sharma
Arti Gupta
Saurabh Kedia
Samagra Agarwal
Namrata Singh
Sandeep Goyal
Saransh Jain
Vipin Gupta
Pabitra Sahu
Sudheer Kumar Vuyyuru
Bhaskar Kante
Raju Sharma
Rajesh Panwar
Peush Sahni
Govind Makharia
Vineet Ahuja
author_facet Sanchit Sharma
Arti Gupta
Saurabh Kedia
Samagra Agarwal
Namrata Singh
Sandeep Goyal
Saransh Jain
Vipin Gupta
Pabitra Sahu
Sudheer Kumar Vuyyuru
Bhaskar Kante
Raju Sharma
Rajesh Panwar
Peush Sahni
Govind Makharia
Vineet Ahuja
author_sort Sanchit Sharma
collection DOAJ
description Background/Aims Exclusive enteral nutrition (EEN), an established modality for pediatric Crohn’s disease (CD) is seldomly utilized in adults. The present study reports the outcome of EEN in adult CD patients at a tertiary care hospital in India. Methods This was a retrospective analysis of CD patients who received EEN as a sole modality/adjunct to other treatment. The primary and secondary outcomes changed in Crohn’s Disease Activity Index (CDAI), and clinical response (decline in CDAI > 70), respectively, at 4 and 8 weeks. Subgroup analysis evaluated response across different phenotypes, EEN formulations and prior treatment. Linear mixed effect model was created to assess the predictors of EEN response. Results Thirty-one CD patients received EEN over median duration of 4 weeks (range, 2–6 weeks). CDAI showed a significant improvement post EEN at 4 (baseline 290 [260–320] vs. 240 [180–280], P=0.001) and 8 weeks (baseline 290 [260–320] vs. 186 [160–240], P=0.001), respectively. The cumulative clinical response rates at 4 and 8 weeks were 37.3% and 80.4% respectively. The clinical response rates at 8 weeks across B1 (n = 4), B2 (n = 18) and B3 (n = 9) phenotypes were 50%, 78.8% and 100% respectively (log-rank test, P=0.093). The response rates at 8 weeks with polymeric (n = 8) and semi-elemental diet (n = 23) were 75% and 82.6%% respectively (log-rank test, P=0.49). Baseline CDAI (odds ratio, 1.008; 95% confidence interval, 1.002–1.017; P=0.046) predicted response to EEN. Conclusions EEN was effective in inducing clinical response across different phenotypes of CD. Baseline disease activity remained the most important predictor of clinical response to EEN.
first_indexed 2024-12-14T22:21:51Z
format Article
id doaj.art-28c3424e40b447e98f215e9df0df9bc8
institution Directory Open Access Journal
issn 1598-9100
2288-1956
language English
last_indexed 2024-12-14T22:21:51Z
publishDate 2021-07-01
publisher Korean Association for the Study of Intestinal Diseases
record_format Article
series Intestinal Research
spelling doaj.art-28c3424e40b447e98f215e9df0df9bc82022-12-21T22:45:28ZengKorean Association for the Study of Intestinal DiseasesIntestinal Research1598-91002288-19562021-07-0119329130010.5217/ir.2019.09172844Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s diseaseSanchit Sharma0Arti Gupta1Saurabh Kedia2Samagra Agarwal3Namrata Singh4Sandeep Goyal5Saransh Jain6Vipin Gupta7Pabitra Sahu8Sudheer Kumar Vuyyuru9Bhaskar Kante10Raju Sharma11Rajesh Panwar12Peush Sahni13Govind Makharia14Vineet Ahuja15 Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India Department of Gastrointestinal Surgery, All India Institute of Medical Sciences, New Delhi, India Department of Gastrointestinal Surgery, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, IndiaBackground/Aims Exclusive enteral nutrition (EEN), an established modality for pediatric Crohn’s disease (CD) is seldomly utilized in adults. The present study reports the outcome of EEN in adult CD patients at a tertiary care hospital in India. Methods This was a retrospective analysis of CD patients who received EEN as a sole modality/adjunct to other treatment. The primary and secondary outcomes changed in Crohn’s Disease Activity Index (CDAI), and clinical response (decline in CDAI > 70), respectively, at 4 and 8 weeks. Subgroup analysis evaluated response across different phenotypes, EEN formulations and prior treatment. Linear mixed effect model was created to assess the predictors of EEN response. Results Thirty-one CD patients received EEN over median duration of 4 weeks (range, 2–6 weeks). CDAI showed a significant improvement post EEN at 4 (baseline 290 [260–320] vs. 240 [180–280], P=0.001) and 8 weeks (baseline 290 [260–320] vs. 186 [160–240], P=0.001), respectively. The cumulative clinical response rates at 4 and 8 weeks were 37.3% and 80.4% respectively. The clinical response rates at 8 weeks across B1 (n = 4), B2 (n = 18) and B3 (n = 9) phenotypes were 50%, 78.8% and 100% respectively (log-rank test, P=0.093). The response rates at 8 weeks with polymeric (n = 8) and semi-elemental diet (n = 23) were 75% and 82.6%% respectively (log-rank test, P=0.49). Baseline CDAI (odds ratio, 1.008; 95% confidence interval, 1.002–1.017; P=0.046) predicted response to EEN. Conclusions EEN was effective in inducing clinical response across different phenotypes of CD. Baseline disease activity remained the most important predictor of clinical response to EEN.http://irjournal.org/upload/pdf/ir-2019-09172.pdfexclusive enteral nutritioncrohn diseasecrohn’s disease activity indexinflammation
spellingShingle Sanchit Sharma
Arti Gupta
Saurabh Kedia
Samagra Agarwal
Namrata Singh
Sandeep Goyal
Saransh Jain
Vipin Gupta
Pabitra Sahu
Sudheer Kumar Vuyyuru
Bhaskar Kante
Raju Sharma
Rajesh Panwar
Peush Sahni
Govind Makharia
Vineet Ahuja
Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
Intestinal Research
exclusive enteral nutrition
crohn disease
crohn’s disease activity index
inflammation
title Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
title_full Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
title_fullStr Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
title_full_unstemmed Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
title_short Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
title_sort efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated crohn s disease
topic exclusive enteral nutrition
crohn disease
crohn’s disease activity index
inflammation
url http://irjournal.org/upload/pdf/ir-2019-09172.pdf
work_keys_str_mv AT sanchitsharma efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT artigupta efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT saurabhkedia efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT samagraagarwal efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT namratasingh efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT sandeepgoyal efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT saranshjain efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT vipingupta efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT pabitrasahu efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT sudheerkumarvuyyuru efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT bhaskarkante efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT rajusharma efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT rajeshpanwar efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT peushsahni efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT govindmakharia efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease
AT vineetahuja efficacyandtolerabilityofexclusiveenteralnutritioninadultpatientswithcomplicatedcrohnsdisease